Foundations 1 is the first of a two-course series centered on developing the core knowledge in the basic, pharmaceutical, clinical and social sciences required for their roles as future health care professionals. Students will learn and apply the course content in the context of their professional roles of scientist, professional, care provider, communicator, collaborator, advocate, scholar, and leader. This course provides the foundation for understanding the pharmacist role in the health care system and explores professional identity.

This is the first in a series of courses which will provide students with the required knowledge, skills, and abilities to effectively manage patients’ drug therapy. Throughout this series of courses, students will learn to integrate evidence-based research, collaborate with other disciplines, and prioritize patient centered care in their future practice.

In the first half of this block, students will explore the critical role of vaccines in reducing infectious diseases, examining the biological mechanisms behind immunity and addressing ethical considerations like equitable access and informed consent. Students will also explore musculoskeletal disorders, GERD, peptic ulcer disease, diarrhea, and constipation, emphasizing the importance of drug formulation, bioavailability, and drug interactions within the gastrointestinal tract. Students will learn how to develop individualized treatment plans, evaluate complementary and alternative medicines, and manage medication adverse effects to ensure safe, effective patient care.

The second half of the block will provide students with an introduction to dermatology (skin and mucous membrane) and eye, ear, nose and throat systems including a focus on the role of self-care and minor ailment prescribing in Ontario. The course will teach the pathophysiology of dermatological and EENT conditions, and related mechanisms of immunity, the importance of drug formulation and vehicles, bioavailability, and drug interactions within the skin and EENT systems.

This is the second in a series of courses which will provide students with the required knowledge, skills, and abilities to effectively manage patients’ drug therapy. Throughout this series of courses, students will learn to integrate evidence-based research, collaborate with other disciplines, and prioritize patient centered care in their future practice.

This course will cover the most common conditions associated with the respiratory and cardiovascular system along with diabetes mellitus. An understanding of anatomy, physiology, pathophysiology, pharmacology will allow students to select the appropriate pharmacotherapy for an individual patient. The students will be able to integrate knowledge of foundational sciences (e.g, pharmaceutics, medicinal chemistry and pharmacokinetics) and social sciences (adherence, health advocacy and social determinants of health) into the care of patients.

This is the third in a series of courses which will provide students with the required knowledge, skills, and abilities to effectively manage patients’ drug therapy. Throughout this series of courses, students will learn to integrate evidence-based research, collaborate with other disciplines, and prioritize patient centered care in their future practice.

This course will cover People Centred Care Across the Lifespan. It is designed to equip students with the knowledge and skills necessary to manage patient cases effectively and safely in topics including thyroid disorders, gender affirming hormone therapy, contraception, polycystic ovarian syndrome, menopause, pregnancy & lactation, osteoporosis and falls and frailty in older adults. Students will learn and apply expertise in physiology, pharmacology, and pharmacotherapy to meet diverse patient needs, ensuring effective and safe clinical decisions. Students will also critically evaluate and apply evidence-based practices. By the end of this course, you will be well-prepared to deliver respectful, individualized, and comprehensive healthcare that supports patient autonomy and fosters a collaborative approach to health across the lifespan. We look forward to helping you become compassionate, knowledgeable, and effective pharmacists.

This is the first of a series of six pharmacy skills and simulation focused courses where students will apply knowledge and develop skills needed to provide patient centred pharmacy care. Students will engage in guided, independent and collaborative learning experiences such as conducting patient interviews, gathering and interpreting health and medication histories, participating in prescription processing, responding to drug information queries, performing physical assessments, and evaluating appropriateness of drug therapy. Students will explore the ethical and legal dimensions of pharmacy practice, including responsible prescribing and decision making that prioritizes patient safety and fosters culturally competent care. Topics covered in this course will align with Applied Therapeutics 1.

This 8-week course is the second in a series of six pharmacy skills and simulation focused courses where students will apply knowledge and develop skills needed to provide patient-centred pharmacy care. Students will engage in guided, independent, and collaborative learning experiences such as conducting patient interviews, gathering and interpreting health and medication histories, performing physical assessments, and evaluating appropriateness of drug therapy. Students will engage with point of care testing (POCT) and interpret these results to assist in optimizing patient care. Demonstration and education of devices and medications commonly used in cardiovascular, respiratory, and diabetes monitoring and treatment will be a focus. Students are expected to continue to adhere to legal and ethical practices, demonstrating responsible decision making that prioritizes patient safety and fosters culturally competent care.

This 8-week course is the third in a series of six pharmacy skills and simulation focused courses where students will apply knowledge and develop skills needed to provide patient-centred pharmacy care. This series of courses will help students develop fundamental knowledge, skills and attitudes intrinsic to the pharmacy student’s professional identity development; these attributes will be transferable to diverse practice settings, and prepare students for practice.

Experiential Learning 1 is the first of two early experiential courses and consists of 160 hours in a community pharmacy practice site completed longitudinally one day per week during Year 1. Students will actively participate in day-to-day activities within a direct patient care community pharmacy practice setting, thus enabling application of knowledge, skills and values learned in faculty-based courses and simulated practice environments (Pharmacy Practice Skills & Simulation laboratories). Students will also participate in a debrief in in-class workshops after Applied Therapeutics courses to discuss their experiences and consolidate their learning with their peers.

Self-care perspectives and pharmacotherapy is the second in a series of Pharmacotherapy courses taught over three years. In addition to covering selected therapeutic topics relating to self-care, (primarily dermatology and EENT) the course will address principles of drug therapy in the practice context of self-care in which pharmacists work unsupervised as the primary health professional contact. It will build and enhance students’ knowledge and skills in the management of minor, self-limiting and self-diagnosed ailments, which is within the scope of practice for pharmacists. Special contextual issues relating to the pharmacist’s role in self-care, particularly communicating with patients; and the pharmacist’s responsibility in accurately assessing and triaging patients, developing care plans and monitoring for this patient population, including special populations of concern. Issues of preventing drug therapy problems related to patient self-selection will be part of patient safety concerns. This course will build on content and skills from PHM101H1 and PHM105H1. The course will be aligned to the other Pharmacotherapy modules and will provide the required knowledge, skills, attitudes and behaviours to effectively manage patients’ drug therapy in incorporating relevant schema recognition, pathophysiology, pharmacology, clinical pharmacokinetics, pharmaceutics and evidence-based authoritative sources of best practice pharmacotherapy.

This course is designed for pharmacy students to develop a broad understanding of pathophysiology, pharmacology, clinical pharmacokinetic and pharmacotherapy in major areas of endocrinology, nephrology and urology. The course will use a problem-based approach with emphasis on the integration and application of fundamental principles to specific clinical situations.

This course is designed to provide students with the knowledge in pathobiology, pharmacology, pharmacotherapy, clinical pharmacokinetics and relevant pharmaceutics required to be a practitioner in infectious diseases therapeutics. The course will be taught using a variety of techniques including on-line lectures, case-based learning and small interactive group learning.

This course is designed to provide students with the knowledge in pathobiology, pharmacology, pharmacotherapy, and clinical pharmacokinetics required to be a practitioner in cardiovascular therapeutics. The course will be taught using a variety of techniques including lectures and team-based learning.

This Medication Therapy Management (MTM) course is the second of the four-part series of simulated pharmacy practice courses. MTM 2 will enable a student to continue to apply knowledge and develop skills needed by a pharmacist to provide patient care, using a systematic patient-care process to define and achieve the goals of optimizing safe, effective pharmacotherapy. MTM 2 course content is drawn from relevant co- and pre-requisite courses. Lectures and simulated practice sessions are designed to facilitate independent and collaborative learning that will be transferrable to diverse practice settings and prepare a student for early experiential learning. Students will be responsible to perform and document a comprehensive patient assessment to identify, resolve and prevent drug therapy problems, and educate patients on the appropriate use of medications. Students will be required to assess a patient’s health status; integrate relevant information to recommend appropriate therapy, determine efficacy and safety endpoints for monitoring therapy, document a care plan, and appropriate follow-up parameters with patients to evaluate their response to therapy, in a simulated practice environment. Students will also actively participate in the medication dispensing process, prepare extemporaneously compounded pharmaceutical products and interpret the pharmacist’s professional, ethical and legal obligation within provincial and federal frameworks.

Medication Therapy Management 3 (MTM 3) is the third of a four-part series of simulated pharmacy practice courses that is delivered longitudinally over three years of the undergraduate program. MTM 3 builds on the skills developed in MTM 1 and MTM 2, focusing on more comprehensive, integrated patient centred care. MTM is founded on the philosophy of Pharmaceutical Care and involves a partnership between the patient, pharmacist, and other health care providers to promote safe and effective medication use to achieve desirable patient outcomes. MTM 3 provides students learning opportunities to apply and integrate materials learned through all courses in the curriculum to date, using simulated practice-based interactions to enhance their patient-care skills. Lectures will provide foundational material and skills which will be applied in the simulated interactions. Simulated interactions will focus on developing effective patient-centered management of multidimensional drug-therapy anchored in a professional context, in preparation for the student’s second year practice experiential course.

Pharmacists are required to apply research evidence in practice. As health care providers, pharmacists discern and translate both the quality and relevance of health information with the goal of optimizing patient outcomes. This course introduces students to clinical trial designs typically used in health care. The course will explore core principles in experimental and non-experimental research designs. The focus will be on randomized controlled trials as they are the primary method of generating evidence for therapeutic interventions. Students will learn how various research approaches are selected, designed, executed, analyzed, published and applied (including critical appraisal). The course covers a broad range of research topics at the introductory to intermediate level. Students will develop foundational knowledge and skills in research methods, statistics and ethics that will be applied in pharmacotherapy modules.

This course surveys the economic aspects of the pharmaceutical sector. The course will use the methods of economic analysis to investigate how markets allocate resources, when they work well and the role for government when they do not work well. Specific topics include the economics of the development of new drugs; economic aspects of drug insurance, economic appraisal of new drugs (“pharmacoeconomics”); and economic models of the pharmacist labour market.

Management skills and related communication and collaboration skills are essential for success in any field of pharmacy practice. This course will provide students with an introduction to basic concepts in management, communication and collaboration with other health and business professionals, and will culminate with the development of a business plan that enables students to apply knowledge and skills. This course is also designed to give students a broad overview in collaborative leadership theory so that they are better prepared to work effectively in their chosen field. Students will learn how pharmacy practice in different settings has evolved from 1985 to 2000 to 2015 as well as how practice may evolve in the future. In doing so students will develop a greater appreciation of the skills required to deliver effective patient care-focused services. Overall, the aim of this course is to equip students with the ability to apply their clinical, pharmaceutical and management skills to provide high quality services that are patient focused and demonstrate value for money.

This course will provide an introduction to physical assessment of patients. Students will engage in lectures, on-line activities, and skills practice in a laboratory setting. This course includes a module pertaining to the administration of substances by injection that allows students to meet the competencies required by the Public Health Agency of Canada and the Ontario College of Pharmacists.

This course will build upon basic pharmacology and medicinal chemistry to make links between the basic sciences and demonstrate how basic principles can be used to improve clinical therapy. It will also include critical evaluation of evidence for specific mechanisms and therapies. The format of the course to address these issues will be online questions that are designed to illustrate these points. The questions will be either multiple choice or short answer. Online feedback will be provided.

This course will provide an introduction to pharmaceutical analysis and discuss the importance of assuring the pharmaceutical quality of medicinal products with an emphasis on establishment of quality control assays and specifications, bioequivalence testing of generic drugs, special considerations for biopharmaceutical products, and the regulatory process in Canada. In addition, the course will discuss the application of analytic techniques in clinical laboratory medicine with a focus on commonly used tests to monitor patient health and the therapeutic use of drugs, including tests for personalized drug therapy. The course includes a laboratory component which will present drug formulation and related quality control issues.

The course provides a brief introduction to the general biology of organisms, and an overview of the host response to infection. Attention is then focused on common bacterial, fungal, viral and parasitic infections of man, and their epidemiology, prevention and treatment. Other topics include sterilization, disinfection, and a survey of antibiotics and chemotherapeutic agents.

This course is the second of two early experiential rotations. Students will undertake EPE-2 during the summer following Year 2 (sometime between May and August). Each student will actively participate in day-to-day services within an institutional pharmacy practice setting, thus enabling application of knowledge, skills and values introduced in faculty-based courses and simulated practice environments (laboratories). Required activities include prescription/medication order processing, patient education, drug information provision, medication history taking, and observation of/participation in patient safety processes in the practice setting. Students also need to demonstrate effective communication skills, professionalism and teamwork during the rotation.

This course is designed to provide pharmacy students with the pathobiology, pharmacology, pharmacotherapy and clinical pharmacokinetics required to be a practitioner in oncology, hematology and immunology therapeutics. The course will be taught using a variety of techniques including on-line lectures, case-based learning and small interactive group learning.

This course is designed to provide pharmacy students with the knowledge in pathobiology, pharmacology, pharmacotherapy and clinical pharmacokinetics required to be a practitioner in neuropsychiatric therapeutics. The course may be taught using a variety of techniques including on-line lectures, case-based learning and small interactive group learning.

Medication Therapy Management 4 (MTM 4) is the final course in a four-part course series that is delivered longitudinally over three years of the undergraduate program. MTM 4 builds on the skills developed in previous MTM courses, offering students opportunities to apply and integrate materials learned through all courses in the curriculum to date. This course focuses on the development of skills required for Expanded Scope of Practice (renewing, modifying and initiating pharmacotherapy) and specifically medication reconciliation. Lectures and applied Simulated Practice Sessions emphasize the pharmacists’ role and responsibilities as a communicator, care provider, collaborator and advocate, to prepare students for their Advanced Pharmacy Practice Experience rotations.

This course will take an issues-oriented, critical-thinking approach to the healthcare system, with a particular emphasis on pharmacy practice. The course will build on the material from PHM110H1, PHM114H1 and PHM215H1, and will allow a deeper look into areas such as quality and patient safety, e-health technology and the health care needs of diverse populations, including Indigenous peoples. Students will also have an opportunity to explore the role of interprofessional collaboration in health care delivery. Week by week students will examine issues with drug supply and access, pharmacy practice reform, expanded services, collaborative care and reimbursement models, and the interconnectivity of the disparate parts of the health care system. By participating in class discussions, reading course reference materials and completing assignments, students will learn to identify and analyze current and emerging health system issues. In the course of doing so, they will also become aware of, understand and appreciate: factors internal and external to pharmacy and medication use that drive change in practice current strategies for evaluating and improving health care and pharmacy practice the role of interprofessional collaboration in the delivery of healthcare emerging roles and opportunities in pharmacy. This course will help students complement their thinking about medications, individual patients, and the clinical encounter with an orientation to the healthcare system as a whole: how it functions, what are some of its key issues, and how do we tackle them.

This course is designed for students who are curious to learn about pharmaceutical public policy at the global level and also to explore the interrelationship between global and domestic health public policy issues, particularly those related to political economy and the governance of the pharmaceutical system. There are no prerequisites required but students are strongly recommended to have taken at least one social science or public health course given the ample reading and research requirements. Particular emphasis will be placed on how governments in different jurisdictions manage their public health responsibilities, particularly in terms of providing access to essential medicines and human development objectives, the tension between economic and health objectives, global trade obligations and their impact on access to medicines, and how pressure from special interest groups are relevant to pharmaceutical policy. Corruption issues will also be addressed. This course encourages a large amount of student participation through group work, discussion, presentations, and debate. Accordingly, students will need to keep up with the weekly readings in order to ensure that they are prepared for the class.

This course is designed to expose students to the pharmaceutical and biopharmaceutical industries, its environment, inner workings, and approach to engaging customers and stakeholders. The course outlines the business model of the industry and covers both drug development and commercialization, from international and Canadian perspectives. The course is intended to broaden the students’ understanding of the industry, introduce critical concepts and terminology, build confidence and prepare students who may seek a career in the industry.

This course will look at patient safety and the potential for medication incidents from two aspects: (1) the medication-use system (e.g., prescribing, order entry, dispensing, administration, and monitoring of drug therapy); and (2) professional practice (e.g., preventable adverse drug events). It will build on topics previously covered in the curriculum, as well as additional materials related to the Institute for Safe Medication Practices Canada, the Canadian Patient Safety Institute, and the concept of continuous quality improvement in pharmacy practice.

The proteins and nucleic acids that are the targets of most prescribed drugs can be classified according to their structure and mechanism of action at the molecular level. In this course, basic concepts of enzyme action such as the mechanisms of enzyme catalysis, the Michaelis-Menten and pre-equilibrium equations, steady-state approximations, allostery and cooperativity will first be covered. Major classes of therapeutic targets will then be discussed with an emphasis on their normal biochemical roles that are exploited for therapeutic intervention. The mechanisms of action of drugs acting on enzymes (antiviral and antimicrobial agents) on nucleic acids and on the cytoskeleton (anti-cancer agents) will be of special interest. The concept of rational cancer therapy will also be covered with examples of drugs targeting growth factors signalling pathways that are dysregulated in cancers.